Retour
Fourchette du Jour
153,00 €
159,19 €
Fourchette 52 Semaines
49,00 €
200,00 €
Volume
125 278
Moyenne 50J / 200J
170,97 €
/
110,33 €
Clôture Précédente
150,83 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -78,6 | 0,3 |
| P/B | 41,8 | 3,0 |
| ROE % | -65,7 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
203,00 €
+30.9%
Low: 187,00 €
High: 223,00 €
BPA Prévisionnel
-2,14 €
CA Est.
25,71M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
22,07 €
14,56 € – 42,72 €
|
1,41B | 2 |
| FY2029 |
16,14 €
10,65 € – 31,23 €
|
985,59M | 2 |
| FY2028 |
8,66 €
2,62 € – 21,95 €
|
563,15M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -0,56 € | -0,38 € | +32,1% |
| 2025-11-10 | -0,53 € | -0,65 € | -22,6% |
| 2025-08-11 | -0,47 € | -0,50 € | -6,4% |
| 2025-05-13 | -0,36 € | -0,45 € | -25,0% |
| 2025-03-17 | -0,30 € | -0,32 € | -6,7% |
| 2024-11-12 | -0,30 € | -0,28 € | +6,7% |
| 2024-08-09 | -0,28 € | -0,31 € | -10,7% |
| 2024-05-13 | -0,34 € | -0,27 € | +20,6% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -29,39M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-65,70%
ROIC-43,15%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio24,31
Interest Coverage0,00
Valorisation
P/E Ratio
-78,59
Forward P/EN/A
P/B Ratio41,83
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -77,61M |
| ROE | -65,70% | ROA | -51,02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -29,39M |
| ROIC | -43,15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,31 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -78,59 | Forward P/E | N/A |
| P/B Ratio | 41,83 | P/S Ratio | N/A |
| PEG Ratio | -0,72 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 237,19 | Fwd Earnings Yield | N/A |
| FCF Yield | -0,48% | ||
| Market Cap | 6,10B | Enterprise Value | 6,07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -77,61M | -36,14M | -31,63M | -12,65M | -9,67M |
| EPS (Diluted) | -2,31 | -1,18 | -1,19 | -0,63 | -0,40 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -84,21M | -40,00M | -31,67M | -12,82M | -9,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 152,13M | 94,64M | 44,27M | 18,35M | 25,74M |
| Total Liabilities | 6,31M | 4,21M | 2,77M | 33,44M | 32,78M |
| Shareholders' Equity | 145,82M | 90,43M | 41,50M | -15,09M | -7,04M |
| Total Debt | 537 000,0 | 886 000,0 | 866 000,0 | 31,81M | 31,81M |
| Cash & Equivalents | 31,68M | 88,16M | 42,09M | 17,34M | 25,62M |
| Current Assets | 147,07M | 89,94M | 42,81M | 17,43M | 25,67M |
| Current Liabilities | 6,05M | 3,63M | 2,10M | 1,64M | 972 000,0 |